Back to mobile site

More on TARS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+54.2% Growth)
- Ratings (9.1 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tarsus Pharmaceuticals (NQ:TARS)
Delayed: 62.61 --0 (-0%)
Prev. Close $62.61  
Open$62.61 
52 Wk High$ 
52 Wk Low$ 
Day High$62.61 
Day Low$62.61 
P/E N/A  
EPS$ 
Volume519 

Friends, Peers and Foes (?): ELAN, ARQT, MIRM NAMS (more...)

Jun 2, 2026 08:31 AM Achieve Life Sciences adds two board members ahead of drug resubmission
Jun 2, 2026 08:30 AM Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
May 28, 2026 04:30 PM Tarsus to Participate in Upcoming Investor Conferences
May 20, 2026 10:40 AM Tarsus Pharmaceuticals (TARS) PT Lowered to $97 at Oppenheimer
May 15, 2026 11:43 AM Form SCHEDULE 13G Tarsus Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC
May 15, 2026 08:47 AM Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: Deep Track Capital, LP
May 14, 2026 08:30 AM Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
May 8, 2026 11:22 AM Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: PRUDENTIAL FINANCIAL INC
May 7, 2026 05:00 PM Tarsus to Participate in Upcoming Investor Conferences
May 6, 2026 05:16 PM Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance
View All Articles

Entities mentioned with TARS

View All Entities